NIH-funded research R01 grant

Vascular AI for guided care in fetal growth restriction

Official title: Vascular Machine Learning Optimized Prognostic and Treatment Pathways in Human Fetal Growth Restriction

Funded at University of Iowa · NIH-11465490 · Data updated 2026-11-12

A new AI-powered approach uses fetal blood flow data to help doctors decide the best time to deliver babies at risk for fetal growth restriction.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startSeptember 1, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$687,798
NIH project number1R01HD123982-01A1
Project IDNIH-11465490 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people with suspected fetal growth restriction or abnormal placental blood flow who require monitoring.

Less likely to help

Patients without signs of fetal growth restriction or abnormal fetal blood flow are unlikely to benefit from this approach.

What this research studies

If your baby’s growth or blood flow is at risk, this project uses machine learning to interpret ultrasound blood-flow patterns and predict outcomes. It aims to help clinicians choose the optimal delivery timing to improve survival and reduce complications. The study builds on prior work showing that AI can spot subtle signals in umbilical artery flow beyond traditional measures. It will use data from pregnant people and their fetuses to develop decision-support tools that clinicians could use at the bedside.

Why it matters

Potential benefit: If successful, this could lead to more precise delivery timing and better outcomes for babies at risk of fetal growth restriction.

How similar studies have gone: Earlier AI analyses of umbilical artery flow have shown improved prediction of FGR risk over traditional methods, supporting potential benefits of this approach.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Santillan, Mark K — University of Iowa
  • Study coordinator: Santillan, Mark K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.